BNP Paribas Call 3000 GIVN 20.06..../ DE000PC1L4B4 /
03/06/2024 09:08:38 | Var.+0.18 | Denaro14:39:39 | Lettera14:39:39 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
13.35EUR | +1.37% | 13.05 Quantità in denaro: 7,000 |
13.07 Quantità in lettera: 7,000 |
GIVAUDAN N | 3,000.00 CHF | 20/06/2025 | Call |
GlobeNewswire
14:54
SRCL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Stericycle to Waste...
Newsfile Corp
14:45
Bassett Furniture Industries, Inc. to Present at Water Tower Research's Inaugural Consumer Products ...
GlobeNewswire
14:42
EXL named a Leader in 2024 Gartner® Magic Quadrant™ for Finance and Accounting Business Process Outs...
GlobeNewswire
14:38
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tu...
GlobeNewswire
14:35
IBN Announces Latest Episode of The Stock2Me Podcast featuring Brian J. Esposito, CEO of Diamond Lak...
GlobeNewswire
14:31
German American Bancorp, Inc. announces the sale of the assets of German American Insurance, Inc. to...
Newsfile Corp
14:30
GoGold Resources Inc. to Participate in THE Mining Investment Event of the North, Canada's Only Tier...
GlobeNewswire
14:30
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce...
GlobeNewswire
14:30
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives...
GlobeNewswire
14:30
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placement...
GlobeNewswire
14:30
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
GlobeNewswire
14:30
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Cli...
GlobeNewswire
14:30
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
GlobeNewswire
14:30
Qlik Signs Strategic Collaboration Agreement with AWS to Accelerate Enterprise AI Adoption
GlobeNewswire
14:20
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial